Connect with us

Technology

Healthcare Revenue Cycle Management (RCM) Software Market size is set to grow by USD 34.8 billion from 2024-2028, Growing need for reducing revenue leakage in healthcare system boost the market, Technavio

Published

on

NEW YORK, Aug. 7, 2024 /PRNewswire/ — The global healthcare revenue cycle management (RCM) software market size is estimated to grow by USD 34.8 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 10.22%  during the forecast period. Growing need for reducing revenue leakage in healthcare system is driving market growth, with a trend towards strategic partnerships and acquisitions. However, interoperability issues associated with healthcare rcm software  poses a challenge. Key market players include 3M Co., ALLSCRIPTS HEALTHCARE SOLUTIONS INC., athenahealth Inc., Change Healthcare Inc., Chetu Inc., Cognizant Technology Solutions Corp., CompuGroup Medical SE and Co. KGaA, Computer Programs and Systems Inc., Epic Systems Corp., Experian Plc, International Business Machines Corp., OSP, Providence Health and Services, Quest Diagnostics Inc., QWay Healthcare Inc., R1 RCM Inc., The SSI Group LLC, Waystar Inc., WellSky Corp., and ZH Healthcare Inc..

Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report

Healthcare Revenue Cycle Management (RCM) Software Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 10.22%

Market growth 2024-2028

USD 34.8 billion

Market structure

Fragmented

YoY growth 2022-2023 (%)

9.37

Regional analysis

North America, Europe, APAC, South America, and Middle East and Africa

Performing market contribution

North America at 50%

Key countries

US, Canada, Germany, UK, and Japan

Key companies profiled

3M Co., ALLSCRIPTS HEALTHCARE SOLUTIONS INC., athenahealth Inc., Change Healthcare Inc., Chetu Inc., Cognizant Technology Solutions Corp., CompuGroup Medical SE and Co. KGaA, Computer Programs and Systems Inc., Epic Systems Corp., Experian Plc, International Business Machines Corp., OSP, Providence Health and Services, Quest Diagnostics Inc., QWay Healthcare Inc., R1 RCM Inc., The SSI Group LLC, Waystar Inc., WellSky Corp., and ZH Healthcare Inc.

Market Driver

The healthcare Revenue Cycle Management (RCM) software market is witnessing a trend of strategic partnerships and acquisitions among market participants. For instance, in August 2020, R1 RCM Inc. Acquired Cerner RevWorks, LLC services business, expanding its revenue cycle capabilities and expertise. Similarly, Centauri Health Solutions Inc. Acquired Applied Revenue Analytics LLC, adding a complementary line of hospital revenue cycle performance services. These collaborations enable RCM software providers to expand their product offerings, enhance their geographic reach, and strengthen their market position. Such strategic moves will lead to the development of new software and platforms, enabling market participants to capitalize on market opportunities and generate sustainable profits. The increase in partnerships and mergers and acquisitions (M&A) activities in the market is anticipated to positively impact the demand for healthcare RCM software worldwide during the forecast period. 

The Healthcare Revenue Cycle Management (RCM) software market is witnessing significant growth in healthcare settings due to the increasing need for efficient sales and revenue cycle management. The services segment of RCM solutions is particularly popular, addressing the lack of trained staff and complexities in billing and payment management. Down coding and claims management are key challenges for healthcare providers, driving demand for advanced RCM software. Cloud deployment models offer scalability and infrastructure reliability, enabling resource acquisition and operational flexibility. Leading RCM software providers like Epic Systems and CareCloud Corporation are investing in cloud-based deployment and interoperability to streamline workflows and ensure data accuracy. Key stakeholders, including healthcare resources and patients, benefit from real-time insights, data integration, and electronic data management. RCM solutions are increasingly adopting HCIT tools and licensing models to address patient volumes and digitization, managing terabytes and petabytes of unstructured and structured data, and normalizing data for improved operational efficiency. Buying behavior is influenced by factors such as billing and payment management applications, claims management, and the need for normalized data. Patent analysis, conference webinars, and industry events provide valuable insights into the latest trends and innovations in the healthcare RCM software market. 

Discover 360° analysis of this market. For complete information, schedule your consultation – Book Here!

Market Challenges

The healthcare revenue cycle management (RCM) software market is experiencing challenges due to interoperability issues. Interoperability enables authorized physicians to access all patient clinical information from different EHR systems. However, the lack of interoperability is leading to increased denials, decreasing revenue generation, and decreased operational efficiency for healthcare service providers. This issue arises due to the use of multiple IT systems with varying data interpretations, multiple vendors for healthcare RCM software, and the growing number of acquisitions in the market. These factors make revenue management challenging, as data is collected from disparate sources with different meanings. Identifying billing errors becomes a struggle when more than one healthcare RCM platform is used. Lack of interoperability between healthcare RCM systems also hinders achieving revenue integrity, especially for large-scale healthcare institutions. With the increasing number of healthcare service providers, interoperability has become essential. Vendors need to develop software that can be used organization-wide, eliminating the need for multiple healthcare RCM software. However, this remains a challenge for vendors, negatively impacting the healthcare RCM software market during the forecast period.The Healthcare Revenue Cycle Management (RCM) software market is experiencing significant growth due to the increasing complexity of the healthcare industry. Challenges include virtual assistance for patient engagement, managing medical images, and ensuring patient access and collections. Denials and patterns require specialized expertise, while Electronic Health Records (EHRs) and healthcare integration demand advanced technology. Health information exchanges and data security are crucial concerns in the healthcare market, with ransomware attacks and data breaches a growing threat. Compliance with regulatory landscapes and financial performance optimization are key areas of focus for healthcare payers and providers. Manufacturing companies and outsourcing services offer product development and optimization, while human resources and contract research/development provide valuable services. Financial outcomes are a top priority, requiring in-house research and facilities to stay competitive in the ecosystem market.

For more insights on driver and challenges – Request a sample report!

Segment Overview 

This healthcare revenue cycle management (rcm) software market report extensively covers market segmentation by 

Deployment 1.1 Cloud-based1.2 On-premisesEnd-user 2.1 Hospitals2.2 Physicians2.3 Medical labsGeography 3.1 North America3.2 Europe3.3 APAC3.4 South America3.5 Middle East and Africa

1.1 Cloud-based-  The healthcare revenue cycle management (RCM) software market is witnessing significant growth, particularly in the cloud-based deployment segment. This trend is driven by the benefits of quick deployment, improved flexibility and scalability, real-time data visibility, and customization capabilities. Cloud-based RCM solutions enable seamless integration with other healthcare software solutions, such as online booking and payment systems. Flexible payment options, including monthly subscriptions and pay-as-you-go models, make these solutions cost-effective for various-sized healthcare organizations. Small and medium-scale healthcare providers are increasingly adopting cloud-based RCM software due to its scalability and cost savings. Large-scale healthcare enterprises, with their vast data volumes, can optimize costs by storing critical data on-premises and infrequently used data on public cloud servers. Innovations in data security will further boost the adoption of cloud-based RCM solutions among large enterprises during the forecast period. In summary, the cloud-based deployment segment is expected to grow at a faster rate than the on-premises deployment segment due to its numerous advantages.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) – Download a Sample Report

Learn and explore more about Technavio’s in-depth research reports

The global healthcare information software market is experiencing robust growth, driven by the increasing need for efficient patient management and data integration. Key segments include Electronic Health Records (EHR), Practice Management Systems, and Telemedicine software. Major players such as Epic Systems, Cerner Corporation, and Allscripts are leading the way with innovative solutions. The market’s expansion is fueled by advancements in AI and data analytics, enhancing healthcare delivery and operational efficiency.

Research Analysis

The Healthcare Revenue Cycle Management (RCM) software market encompasses the sales of management software and services designed to streamline and optimize revenue processes in healthcare settings. These solutions facilitate payment management, claims processing, and resource acquisition, addressing scalability constraints and infrastructure reliability. Cloud deployment models offer flexibility and accessibility, while operational frameworks ensure compliance with HCIT tools and regulatory requirements. Normalized data, licensing, implementation, IT support, and maintenance services are essential components of RCM solutions. Custom interfaces, verification, and validation are critical for seamless integration with hospital associations, healthcare facilities, and emerging countries. Legacy systems pose challenges, but AI, machine learning, algorithms, and predictive analytics are transforming RCM, enabling more efficient down coding and claims management. In the dynamic healthcare landscape, RCM software plays a pivotal role in enhancing operational efficiency and financial performance, ultimately improving patient care.

Market Research Overview

The Healthcare Revenue Cycle Management (RCM) software market is a significant segment of the Healthcare IT (HCIT) industry, focusing on automating and optimizing billing and payment processes in healthcare settings. Sales of RCM software and services have been growing steadily due to the increasing complexity of healthcare billing and the need for improved operational efficiency. RCM solutions cater to various healthcare providers, including clinics, laboratories, and hospitals. However, the implementation and effective utilization of these systems face challenges such as a lack of trained personnel, down coding, and scalability constraints. Cloud deployment models have gained popularity due to their flexibility and cost-effectiveness. However, concerns around infrastructure reliability and data security persist. The operational framework of RCM software involves billing and payment management applications, claims management, and data integration. Key stakeholders include healthcare providers, patients, and key players in the RCM market, such as Epic Systems and CareCloud Corporation. Buying behavior is influenced by factors like data accuracy, interoperability, and real-time insights. The market size is vast, with terabytes and even petabytes of data being generated daily from unstructured and structured sources. Normalized data is crucial for effective RCM. HCIT tools like licensing, implementation, IT support, and maintenance services are essential for successful RCM implementation. The RCM market is influenced by various trends, including digitization, artificial intelligence, machine learning, and predictive analytics. Emerging countries are adopting RCM solutions to improve their healthcare systems. However, challenges like legacy systems, data privacy, and security landscape remain. The healthcare market is continuously evolving, with new technologies like virtual assistance, medical images, and drug discovery shaping the future. Human resources, patient access, collections, denials, and patterns are critical areas of focus for RCM solutions. The healthcare privacy and security landscape are major concerns, with ransomware attacks like the Accellion FTA breach highlighting the importance of robust security measures. Patient records and electronic patient data exchange are crucial for effective RCM. In conclusion, the Healthcare RCM software market is a dynamic and complex industry, requiring a deep understanding of healthcare resources, workflows, and HCIT tools. Effective RCM implementation involves addressing challenges like data accuracy, interoperability, and scalability constraints while leveraging emerging technologies to improve operational efficiency and patient care.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

DeploymentCloud-basedOn-premisesEnd-userHospitalsPhysiciansMedical LabsGeographyNorth AmericaEuropeAPACSouth AmericaMiddle East And Africa

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/healthcare-revenue-cycle-management-rcm-software-market-size-is-set-to-grow-by-usd-34-8-billion-from-2024-2028–growing-need-for-reducing-revenue-leakage-in-healthcare-system-boost-the-market-technavio-302215625.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

VERNAL CAPITAL ACQUISITION CORP. ANNOUNCES PRICING OF $100 MILLION INITIAL PUBLIC OFFERING

Published

on

By

NEW YORK, May 5, 2026 /PRNewswire/ — Vernal Capital Acquisition Corp. (NYSE: VECA) (“Vernal”) announced the pricing of its initial public offering (the “IPO”) of 10,000,000 units at $10.00 per unit. The units are expected to trade on the New York Stock Exchange (“NYSE”) under “VECAU” beginning May 6, 2026. Each unit consists of one ordinary share and one right to receive one-fourth of one ordinary share upon consummation of an initial business combination. Upon separate trading, the ordinary shares and rights are expected to be listed on NYSE under “VECA” and “VECAR,” respectively.

D. Boral Capital LLC is acting as sole book-running manager of the offering. The underwriters have a 45-day option to purchase up to 1,500,000 additional units to cover any over-allotments. The offering is expected to close on May 7, 2026, subject to customary closing conditions.

A registration statement for these securities was declared effective by the SEC on May 5, 2026. The offering is made only by means of a prospectus. Copies of the prospectus may be obtained, from D. Boral Capital LLC, 590 Madison Ave., 39th Floor, New York, New York 10022, by telephone at (212) 970-5150 or by email at dbccapitalmarkets@dboralcapital.com.

This press release shall not constitute an offer to sell or to buy, nor shall there be any sale where such offer, solicitation or sale would be unlawful prior to registration or qualification under the applicable securities laws.

About Vernal

Vernal is a blank check company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Vernal’s target search will not be limited to a particular industry or geographic region.

Forward-Looking Statements

This press release contains “forward-looking statements,” including statements regarding Vernal’s IPO. These statements are subject to risks and uncertainties that could cause actual results to differ materially. No assurance can be given that the offering will be completed on the terms described, or at all. Forward-looking statements are subject to numerous conditions, beyond Vernal’s control, including those in the Risk Factors section of Vernal’s registration statement filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. Vernal disclaims any obligation to release publicly updates or revisions to any forward-looking statements to reflect any change in Vernal’s expectations, except as required by law.

Contact

Binghan Yi, CFO
binghan@vernal.com
www.vernalspac.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/vernal-capital-acquisition-corp-announces-pricing-of-100-million-initial-public-offering-302763378.html

SOURCE Vernal Capital Acquisition Corp.

Continue Reading

Technology

RIVANNA nominated for MedTech Scale-Up of the Year at MedTech World Awards 2026 | North America

Published

on

By

Nomination places the Charlottesville-based company among growth-stage medtech leaders recognized for commercial momentum in AI-powered clinical decision support; public voting is open through May 8

CHARLOTTESVILLE, Va., May 5, 2026 /PRNewswire/ — RIVANNA®, developer of AI-powered clinical decision-support solutions, today announced that it has been nominated for MedTech Scale-Up of the Year at the MedTech World Awards 2026 | North America. Public voting is open through Friday, May 8, 2026, with category winners to be announced at the inaugural North American Awards Gala on May 11, 2026, at the Hilton West Palm Beach in Florida.

The MedTech Scale-Up of the Year category honors a growth-stage company successfully scaling revenues, partnerships, and adoption across the global medical technology ecosystem. Nominees across the program’s 22 categories were selected through a structured process led by the MedTech World Steering Committee, with category winners determined by a combination of expert evaluation and public voting from the global MedTech community.

“We have built RIVANNA on validation earned from the most rigorous technical buyers in healthcare: competitive federal awards translated into FDA-cleared products, each paired with a commercial program that meets clinicians where they work,” said Will Mauldin, PhD, Co-founder and CEO of RIVANNA. “Being nominated for MedTech Scale-Up of the Year is a meaningful affirmation of that approach and the team executing it.”

Public voting closes Friday, May 8, 2026. Members of the MedTech community are invited to support RIVANNA’s nomination at the official voting page: vote here.

The award nomination follows a year of measurable scaling for RIVANNA:

In October 2025, RIVANNA reported on being named a finalist in MedTech Innovator’s 2025 Early-Stage Grand Prize competition, selected from nearly 1,500 global applicants to represent the top 4% of medtech innovations worldwide.In December 2025, RIVANNA reported on the U.S. Food and Drug Administration’s 510(k) clearance of its Accuro® 3S Needle Guide Kit consumables, building on existing Accuro 3S device clearance.In April 2026, RIVANNA reported on peer-reviewed findings, published in 2025 in the Journal of Emergency Medicine (DOI: 10.1016/j.jemermed.2025.11.011), showing that the Accuro® XV musculoskeletal imaging system enables non-physician operators to acquire diagnostic-quality scans after just one hour of hands-on training.In May 2026, RIVANNA reported on the U.S. Food and Drug Administration’s 510(k) clearance of the Accuro® XV Diagnostic Ultrasound System for musculoskeletal imaging, authorizing commercial use across hospital and clinic settings.The company’s clinical program now spans eight sites nationwide with more than 1,500 patients enrolled.

The 2026 MedTech World Awards | North America, powered by Blue Goat Cyber, will be presented Monday, May 11, 2026, at the inaugural North American Awards Gala at the Hilton West Palm Beach, marking the first time the MedTech World Awards have been hosted in the United States.

About the MedTech Scale-Up of the Year Award
Presented by MedTech World, the MedTech Scale-Up of the Year category recognizes growth-stage medical technology companies demonstrating strong commercial momentum, expanding partnerships, and accelerating real-world adoption. The award is one of 22 categories spanning innovation, clinical excellence, regulatory strategy, investment, and leadership across the global MedTech ecosystem.

About RIVANNA
RIVANNA® is a medical technology company developing clinical decision-support solutions powered by proprietary clinical datasets, AI models, and purpose-built imaging hardware. The company’s platform automates complex anatomical analysis at the point of care, enabling faster, more confident clinical decisions while reducing variability and expanding access to advanced capabilities. The first applications target significant market opportunities in regional anesthesia and fracture care. RIVANNA has built a proven FDA regulatory track record across its Accuro® platform, with device clearances for Accuro® 3S (spinal needle guidance) and Accuro® XV (musculoskeletal imaging), a portfolio of supporting cleared consumables, and AI software modules advancing through regulatory review. The company is backed by 100+ patents and validated through clinical partnerships with leading academic medical centers. RIVANNA is headquartered in Charlottesville, Virginia, and operates an FDA-registered, ISO 13485:2016-certified manufacturing facility. Learn more at rivannamedical.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/rivanna-nominated-for-medtech-scale-up-of-the-year-at-medtech-world-awards-2026–north-america-302763342.html

SOURCE RIVANNA

Continue Reading

Technology

D2L Launch Week Highlights Latest Product Releases

Published

on

By

Latest innovations are designed to save time, simplify workflows, and help drive better learning outcomes

TORONTO, May 5, 2026 /PRNewswire/ – D2L, a global leader in learning innovation, hosted its first-ever D2L Launch Week, a four-day virtual webinar series spotlighting the company’s latest product innovations across D2L Brightspace in 2026.

Throughout the week, D2L showcased a range of product releases through live demos and practical customer use cases, highlighting how institutions, school districts and organizations can help to drive engagement and improve learning outcomes. The featured updates include enhancements to D2L Lumi for idea generation, intervention suggestions, quiz creation and summarization; tools to strengthen parent and guardian outreach; and administrative capabilities designed to help large organizations delegate course and configuration management more effectively.

“We’re proud to showcase the ways D2L continues to innovate to help make learning more personalized, efficient, and scalable,” said Christian Pantel, Chief Product Officer at D2L. “From new D2L Lumi features to enhanced communication tools and more flexible distributed administration capabilities, these updates are designed to help our customers save time, improve usability, and deliver better learning experiences at scale.”

Enhancements to D2L Lumi

Among the new capabilities were several updates to D2L’s AI-native tool, D2L Lumi, designed to improve usability, transparency, and alignment across workflows, including:

D2L Lumi Ideas: Generates assignment and discussion ideas directly within Brightspace, making it easier to generate high quality content aligned to learning outcomes.D2L Lumi Insights: Gives educators access to learning intervention suggestions, designed to provide recommended next steps based on learner data.D2L Lumi Quiz: Helps educators generate questions from multiple course content topics and includes a more streamlined question-generation workflow.D2L Lumi Summary: Supports summarization from more content sources, including nested submodules, and can give educators the ability to preview and adjust source text before summarization.

Updates to Parent and Guardian Communications

D2L also introduced new parent and guardian communication enhancements to help K-12 educators strengthen engagement beyond the classroom. Teachers can now send bulk emails to all parents and guardians associated with students in their class. For individual student outreach, teachers can also email parents and guardians of a specific learner, making it easier to share timely updates on student progress and classroom activity.

Manage Distributed Administration at Scale

Distributed Administration gives organizations more flexibility to delegate administrative responsibilities across organization levels. With Distributed Administration, administrators can manage specific areas, enabling them to oversee courses while helping to reduce bottlenecks and free up time.

Learn more about the latest product releases showcased at D2L Launch Week.

About D2L   
D2L is transforming the way the world learns, helping learners achieve more than they dreamed possible. Working closely with customers all over the world, D2L is on a mission to make learning more inspiring, engaging and human. Find out how D2L helps transform lives and delivers outstanding learning outcomes in K-12, higher education and businesses.

D2L Media Contact
PR@D2L.com
X: @D2L
© 2026 D2L Corporation.

The D2L family of companies includes D2L Inc., D2L Corporation, D2L Ltd, D2L Australia Pty Ltd, D2L Europe Ltd, D2L Asia Pte Ltd, D2L India Pvt Ltd, D2L Brasil Soluções de Tecnologia para Educação Ltda and D2L Sistemas de Aprendizaje Innovadores, S. D2 R.L de C.V., and H5P Group AS.

All D2L and H5P marks are owned by the D2L group of companies. Please visit D2L.com/trademarks for a list of D2L marks. All other trademarks are the property of their respective owners.

View original content to download multimedia:https://www.prnewswire.com/news-releases/d2l-launch-week-highlights-latest-product-releases-302763345.html

SOURCE D2L

Continue Reading

Trending